An Israeli doctor in Padua tells Zman Yisrael, The Times of Israel’s Hebrew-language sister site, about treatments that have been effective in Italy.
“In the past few days, people have begun to recover, in part due to new medications and also as a result of the fact that it takes some two weeks to recover from the virus,” says Carmi Sheffer.
He attributes the high death rates in Italy to the spread within geriatric hospitals. “The moment the virus arrives in a place where an elderly population is concentrated, it spreads like wildfire,” he says.
In Padua, the autoimmune medicine Tocilizumab has proven effective, but can only be used once established that no other viruses are present in the patients’ bodies, he says. The hospital where he works has also seen positive results from the antiviral drug Remdesivir, he says.
“We will control the virus and flatten the curve within a few weeks, but the closure will continue until June,” he predicts. “Italy is ahead of Israel by something like a month, so in my opinion, [in Israel] it will end only in July.”
But he also predicts that Israel could see soaring death rates, like Italy.
“I do not think the Israeli health care system is prepared for an outbreak on this scale. Israel’s advantage is the army, which can build field hospitals to treat mild cases, which is should,” he says.
It's not (only) about you.
Supporting The Times of Israel isn’t a transaction for an online service, like subscribing to Netflix. The ToI Community is for people like you who care about a common good: ensuring that balanced, responsible coverage of Israel continues to be available to millions across the world, for free.
Sure, we'll remove all ads from your page and you'll unlock access to some excellent Community-only content. But your support gives you something more profound than that: the pride of joining something that really matters.
Join the Times of Israel Community
Join our Community
Already a member? Sign in to stop seeing this
You're a dedicated reader
We’re really pleased that you’ve read X Times of Israel articles in the past month.
That’s why we started the Times of Israel ten years ago - to provide discerning readers like you with must-read coverage of Israel and the Jewish world.
So now we have a request. Unlike other news outlets, we haven’t put up a paywall. But as the journalism we do is costly, we invite readers for whom The Times of Israel has become important to help support our work by joining The Times of Israel Community.
For as little as $6 a month you can help support our quality journalism while enjoying The Times of Israel AD-FREE, as well as accessing exclusive content available only to Times of Israel Community members.
Thank you,
David Horovitz, Founding Editor of The Times of Israel
Join Our Community
Join Our Community
Already a member? Sign in to stop seeing this
comments